Dexcom (DXCM) Q2 FY2026 earnings: revenue $1.3 billion, up 13.1% on the year
Dexcom Inc. (DXCM) reported revenue of $1.3 billion for Q2 FY2026, the quarter ended 30 June 2026, up 13.1% on the same quarter a year earlier. Net income was $249 million, up 38.5% on the year, and diluted earnings per share $0.64. The figures are the company's own, from the 10-Q it filed with the SEC on 30 July 2026.
Revenue
$1.3 billion
+13.1% on the year · +9.8% on the quarter
Q3 FY2024Q2 FY2026
Operating margin
24.3%
18.4% a year earlier
Q3 FY2024Q2 FY2026
Net income
$249 million
+38.5% on the year · +24.9% on the quarter
Q3 FY2024Q2 FY2026
Diluted EPS
$0.64
+42.2% on the year · +25.5% on the quarter
Q3 FY2024Q2 FY2026
this quarterthe same quarter a year earlierHover a bar for its figure.
What management said
Guidance figures: 3 raised, 1 narrowed.
Revenue rose 13% to $1.308 billion: Organic revenue grew 12% to $1.298 billion, excluding $9.9 million of foreign exchange impact and $0.2 million of acquired non-CGM revenue. Prior-year reported revenue was $1.157 billion.
GAAP earnings per share rose to $0.64: GAAP net income was $249.1 million, or $0.64 per diluted share, against $179.8 million, or $0.45 per diluted share, a year earlier.
Non-GAAP gross margin reached 64.1%: Non-GAAP gross profit was $838.5 million, or 64.1% of reported revenue, against 60.1% a year earlier. GAAP gross margin was 63.4%, against 59.5%.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
Q2 FY2026
Q1 FY2026
Q2 FY2025
On the quarter
On the year
Last 8 quarters
Operating cash flow
269
526
303
-48.8%
-11.2%
Capital expenditure
84.7
76.6
94.1
+10.6%
-10.0%
Free cash flow
184
449
209
-58.9%
-11.7%
Free cash flow margin
14.1%
37.7%
18.1%
Cash from investing
330
-298
-63.6
Cash from financing
-607
-25.0
-1.7
Depreciation and amortisation
68.2
67.1
63.0
+1.6%
+8.3%
Share-based compensation
39.0
43.3
45.3
-9.9%
-13.9%
Diluted shares, weighted
390m
394m
408m
-0.9%
-4.4%
Shares outstanding at period end
377m
386m
392m
-2.2%
-3.8%
Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.
Balance sheet
$ million
Q2 FY2026
Q1 FY2026
Q2 FY2025
On the quarter
On the year
Last 8 quarters
Shareholders' equity
2,621
2,957
2,573
-11.3%
+1.9%
Debt
1,243
1,242
2,445
+0.1%
-49.2%
Operating lease liabilities
82.6
69.0
54.7
+19.7%
+51.0%
Finance lease liabilities
52.3
53.5
56.2
-2.2%
-6.9%
Other liabilities
2,456
2,312
2,198
+6.2%
+11.7%
Total liabilities and equity
6,455
6,633
7,327
-2.7%
-11.9%
Goodwill
24.1
24.2
24.1
-0.4%
0.0%
Intangible assets
102
62.6
87.2
+62.3%
+16.5%
Investments
210
220
116
-4.6%
+80.9%
Cash and equivalents
1,105
1,118
1,159
-1.2%
-4.7%
Receivables
1,258
1,089
1,349
+15.5%
-6.8%
Inventory
726
694
571
+4.7%
+27.3%
Other assets
3,031
3,427
4,021
-11.5%
-24.6%
Total assets
6,455
6,633
7,327
-2.7%
-11.9%
Questions
What was Dexcom's revenue in Q2 FY2026?
Dexcom (DXCM) reported revenue of $1.3 billion for Q2 FY2026, the quarter ended 30 June 2026, up 13.1% on the same quarter a year earlier.
How much did Dexcom earn in Q2 FY2026?
Net income for Q2 FY2026 was $249 million, up 38.5% on the year, and diluted earnings per share $0.64.
When did Dexcom report Q2 FY2026 results?
Dexcom filed its 10-Q for the quarter ended 30 June 2026 with the SEC on 30 July 2026.
Each quarter as filed, linked to its filing. Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. A quarter marked † is shown as the company last restated it in a later filing, so it compares with the quarters around it on one basis; rest on a figure for the one first filed. EPS is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.
10-Q for the period ended 30 June 2026, filed 30 July 2026: the filing.